Apollo Medical (NASDAQ:AMEH) Shares Gap Down to $27.43

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) gapped down prior to trading on Thursday . The stock had previously closed at $27.43, but opened at $26.85. Apollo Medical shares last traded at $26.85, with a volume of 100 shares.

A number of brokerages have recently issued reports on AMEH. Zacks Investment Research raised Apollo Medical from a “hold” rating to a “buy” rating and set a $30.00 price target on the stock in a report on Friday, March 12th. TheStreet raised Apollo Medical from a “c+” rating to a “b-” rating in a report on Tuesday, January 5th.

The firm has a 50 day moving average price of $25.90 and a 200 day moving average price of $20.89. The company has a quick ratio of 2.79, a current ratio of 2.79 and a debt-to-equity ratio of 0.99. The stock has a market cap of $1.43 billion, a P/E ratio of 28.51, a P/E/G ratio of 4.29 and a beta of 0.49.

Apollo Medical (NASDAQ:AMEH) last posted its quarterly earnings data on Tuesday, March 9th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.18 by $0.09. Apollo Medical had a return on equity of 16.69% and a net margin of 5.01%. The firm had revenue of $176.78 million for the quarter. Equities analysts predict that Apollo Medical Holdings, Inc. will post 0.92 earnings per share for the current fiscal year.

In related news, major shareholder Physicians Of Californi Allied sold 1,638,045 shares of the stock in a transaction dated Thursday, April 1st. The stock was sold at an average price of $24.50, for a total transaction of $40,132,102.50. Following the completion of the sale, the insider now owns 17,307,214 shares in the company, valued at $424,026,743. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 11.87% of the stock is owned by company insiders.

Large investors have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. grew its position in shares of Apollo Medical by 162.0% during the third quarter. JPMorgan Chase & Co. now owns 120,150 shares of the company’s stock worth $2,086,000 after purchasing an additional 74,294 shares in the last quarter. Virginia Retirement Systems ET AL purchased a new position in Apollo Medical during the 4th quarter valued at approximately $185,000. Wells Fargo & Company MN grew its holdings in Apollo Medical by 12.3% during the 3rd quarter. Wells Fargo & Company MN now owns 54,295 shares of the company’s stock valued at $974,000 after buying an additional 5,958 shares in the last quarter. California State Teachers Retirement System grew its holdings in Apollo Medical by 97.2% during the 3rd quarter. California State Teachers Retirement System now owns 29,967 shares of the company’s stock valued at $538,000 after buying an additional 14,774 shares in the last quarter. Finally, Strs Ohio purchased a new position in Apollo Medical during the 3rd quarter valued at approximately $269,000. Hedge funds and other institutional investors own 9.32% of the company’s stock.

About Apollo Medical (NASDAQ:AMEH)

Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare management company, provides medical care services. The company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver quality care to its patients.

Recommended Story: Different Types of Derivatives

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.